Selectquote Inc Stock Price, News & Analysis

SelectQuote (NYSE: SLQT) reported its Q3 FY2025 results with consolidated revenue of $408.2 million, up from $376.4 million in Q3 FY2024. Net income reached $26.0 million, a significant increase from $8.6 million year-over-year, while Adjusted EBITDA was $37.7 million compared to $46.6 million in Q3 FY2024. The company's performance was driven by strong execution across segments: Senior generated revenue of $169.4 million with 168,001 approved Medicare Advantage policies, Healthcare Services achieved revenue of $189.6 million with 105,523 SelectRx members (41% YoY growth), and Life segment revenue reached $45.8 million. For FY2025, SelectQuote expects revenue between $1.500-$1.575 billion and net income ranging from $(1) million to $28 million.

SelectQuote (NYSE: SLQT) has issued a strong response to recent Department of Justice (DoJ) allegations regarding the Medicare Advantage industry. The company, which has been operating for over 40 years and served more than 8 million Americans, firmly rejects the DoJ's complaint and states it will defend its reputation. SelectQuote emphasizes that it has been cooperating with DoJ inquiries since 2022 and maintains that the allegations are incorrect and demonstrate a lack of understanding of their business model. The company particularly highlights its work with underserved communities, noting that their customer base includes a higher proportion of low-income seniors and individuals with chronic diseases compared to national averages, with dual special needs plan qualifiers at twice the national rate.

SelectQuote (NYSE: SLQT), a leading Medicare insurance policy distributor and healthcare services platform provider, has scheduled its fiscal third quarter 2025 earnings release for May 12, 2025, before market open. The company will host a conference call on the same day at 8:30 am ET, featuring CEO Tim Danker and CFO Ryan Clement to discuss the quarterly results.

Interested participants can register for the conference call through a provided link, with registration remaining open through the live call. The event will also be available via webcast on SelectQuote's investor relations website.

SelectQuote (NYSE: SLQT) has successfully closed a $350 million strategic investment from Bain Capital, Morgan Stanley Private Credit, and Newlight Partners on February 28, 2025. The company, which specializes in Medicare insurance policy distribution and healthcare services, has allocated $260 million of the proceeds to reduce its outstanding term loan.

Following this transaction, SelectQuote now maintains over $100 million in available liquidity to support its insurance distribution and healthcare services operations. The deal also brings strategic leadership additions, with Chris Wolfe from Bain Capital Insurance and Srdjan Vukovic from Newlight Partners joining the Board of Directors, each contributing over 20 years of investing and healthcare sector expertise.

SelectQuote (NYSE: SLQT) has secured a $350 million strategic investment from Bain Capital, Morgan Stanley Private Credit, and Newlight Partners. This investment will help the company recapitalize its balance sheet, reduce annual cash debt service, and provide liquidity for growth initiatives. The company has also successfully renegotiated its Senior Secured Credit Facility at a lower interest rate.

As part of the transaction, Chris Wolfe from Bain Capital and Srdjan Vukovic from Newlight Partners will join SelectQuote's Board of Directors upon closing, expected on February 28, 2025. Both executives bring over 20 years of healthcare sector experience. The deal follows SelectQuote's 2024 receivables securitization, marking progress toward refinancing and deleveraging goals.

SelectQuote (NYSE: SLQT) reported strong Q2 FY2025 results with consolidated revenue of $481.1 million, up from $405.4 million in Q2 FY2024. Net income reached $53.2 million, significantly higher than $19.4 million in the previous year. Adjusted EBITDA grew to $87.5 million from $67.4 million.

The Senior segment generated revenue of $255.6 million with Adjusted EBITDA of $100.5 million, achieving a 39% margin. Healthcare Services revenue was $183.4 million with SelectRx members growing 54% year-over-year to 96,695. Life segment revenue reached $39.9 million.

The company announced a $350 million strategic investment led by Bain Capital and Morgan Stanley Private Credit. For FY2025, SelectQuote expects revenue between $1.500-1.575 billion, net income between $(24) million to $11 million, and Adjusted EBITDA of $115-140 million.

SelectQuote (NYSE: SLQT), a leading distributor of Medicare insurance policies and Healthcare Services platform owner, has announced it will release its fiscal second quarter 2025 financial results after market close on Monday, February 10, 2025.

CEO Tim Danker and CFO Ryan Clement will host a conference call at 5:00 pm ET on the same day to discuss the results. Interested parties can register for the conference call through the provided link, with registration remaining open through the live call. The company recommends registering at least 10 minutes before the call starts to ensure full participation.

The event will also be available via webcast through SelectQuote's investor relations website.

SelectQuote (NYSE: SLQT) reported Q1 FY2025 results with revenue of $292.3 million, up from $232.7 million in Q1 FY2024. The company posted a net loss of $44.5 million, compared to a $31.1 million loss in the prior year period. Segment highlights include Senior Revenue of $92.9 million, Healthcare Services Revenue of $155.7 million with 86,521 SelectRx members (64% growth), and Life Revenue of $39.3 million.

For FY2025, SelectQuote expects revenue between $1.425-$1.525 billion, net income/loss range of $(59) million to $3 million, and Adjusted EBITDA of $100-130 million.

SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a growing Healthcare Services platform, has announced the release of its fiscal first quarter 2025 financial results. The results will be made public before market open on Monday, November 4, 2024.

Following the release, CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss the results. Interested parties can register for the call using the provided link. The event will also be webcasted live via the company's investor relations website.